The University of Southampton
University of Southampton Institutional Repository

Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations

Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations
Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations
Mosaic loss of the Y-chromosome (LOY) is the most common somatic alteration in men. We aimed to assess the relationship between LOY and serum biomarkers in UK Biobank and explore the interaction with constitutional and somatic genetics. LOY was strongly associated with levels of sex hormone binding globulin (SHBG, β=0.12, PFDR= P = 7.44×10−36, adjusted for age, age squared, gender, smoking status, smoking intensity and principal genetic components), a key regulator of testosterone bioavailability associated with diverse disorders including cancer and autoimmune diseases. Furthermore, LOY was associated with total testosterone (TT, β=0.09, PFDR=2.23 × 10−20), but not bioavailable testosterone (PFDR=0.46) or free testosterone (PFDR=0.75). These relationships remained significant after sensitivity analysis that included comorbidities and body mass index (SHBG, β = 0.08, PFDR = 4.61×10−21; TT, β = 0.05, PFDR = 4.13 × 10−9). Mendelian randomisation suggested a causal effect of SHBG on LOY in BioBank Japan (P=6.58×10−4) but there was no evidence for an effect of LOY on SHBG (P=0.46). Assessment of cis-eQTLs for 13 genes associated with LOY identified two SNPs that were also associated with levels of SHBG, however only rs7141210 (imprinted DLK1-MEG3 locus) modified the relationship between SHBG and LOY (rs7141210-T/T; Pinteraction=0.04) with low levels of SHBG seen specifically in men without LOY (β=-0.02, P=0.001), but not those with LOY (P=0.41). Age-related clonal hematopoiesis (CH) defined by somatic driver mutations was not associated with sex hormone levels but was associated with LOY at clonal fractions >30% (OR=1.52, P=2.92×10−4). TET2, TP53, and CBL mutations were enriched in high level LOY cases, but not DNMT3A or ASXL1. Our findings thus identify independent relationships between LOY, sex hormones and CH.
2375-2548
Dawoud, Ahmed A. Z.
01e458e9-68ea-45c1-9e8b-ef85e9ccc35e
Tapper, William J.
9d5ddc92-a8dd-4c78-ac67-c5867b62724c
Cross, Nicholas C. P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Dawoud, Ahmed A. Z.
01e458e9-68ea-45c1-9e8b-ef85e9ccc35e
Tapper, William J.
9d5ddc92-a8dd-4c78-ac67-c5867b62724c
Cross, Nicholas C. P.
f87650da-b908-4a34-b31b-d62c5f186fe4

Dawoud, Ahmed A. Z., Tapper, William J. and Cross, Nicholas C. P. (2023) Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations. Science Advances. (doi:10.1101/2022.09.05.22279615).

Record type: Article

Abstract

Mosaic loss of the Y-chromosome (LOY) is the most common somatic alteration in men. We aimed to assess the relationship between LOY and serum biomarkers in UK Biobank and explore the interaction with constitutional and somatic genetics. LOY was strongly associated with levels of sex hormone binding globulin (SHBG, β=0.12, PFDR= P = 7.44×10−36, adjusted for age, age squared, gender, smoking status, smoking intensity and principal genetic components), a key regulator of testosterone bioavailability associated with diverse disorders including cancer and autoimmune diseases. Furthermore, LOY was associated with total testosterone (TT, β=0.09, PFDR=2.23 × 10−20), but not bioavailable testosterone (PFDR=0.46) or free testosterone (PFDR=0.75). These relationships remained significant after sensitivity analysis that included comorbidities and body mass index (SHBG, β = 0.08, PFDR = 4.61×10−21; TT, β = 0.05, PFDR = 4.13 × 10−9). Mendelian randomisation suggested a causal effect of SHBG on LOY in BioBank Japan (P=6.58×10−4) but there was no evidence for an effect of LOY on SHBG (P=0.46). Assessment of cis-eQTLs for 13 genes associated with LOY identified two SNPs that were also associated with levels of SHBG, however only rs7141210 (imprinted DLK1-MEG3 locus) modified the relationship between SHBG and LOY (rs7141210-T/T; Pinteraction=0.04) with low levels of SHBG seen specifically in men without LOY (β=-0.02, P=0.001), but not those with LOY (P=0.41). Age-related clonal hematopoiesis (CH) defined by somatic driver mutations was not associated with sex hormone levels but was associated with LOY at clonal fractions >30% (OR=1.52, P=2.92×10−4). TET2, TP53, and CBL mutations were enriched in high level LOY cases, but not DNMT3A or ASXL1. Our findings thus identify independent relationships between LOY, sex hormones and CH.

Text
Dawoud 2023 for Pure - Accepted Manuscript
Download (1MB)
Text
2022.09.05.22279615v1.full - Accepted Manuscript
Download (1MB)

More information

Accepted/In Press date: 22 March 2023
e-pub ahead of print date: 21 April 2023
Published date: 21 April 2023

Identifiers

Local EPrints ID: 476397
URI: http://eprints.soton.ac.uk/id/eprint/476397
ISSN: 2375-2548
PURE UUID: 11b0685c-8662-4ec7-97d0-f361ebe10ecd
ORCID for Ahmed A. Z. Dawoud: ORCID iD orcid.org/0000-0003-0164-7773
ORCID for William J. Tapper: ORCID iD orcid.org/0000-0002-5896-1889
ORCID for Nicholas C. P. Cross: ORCID iD orcid.org/0000-0001-5481-2555

Catalogue record

Date deposited: 20 Apr 2023 16:31
Last modified: 29 Oct 2024 03:11

Export record

Altmetrics

Contributors

Author: Ahmed A. Z. Dawoud ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×